(Total Views: 334)
Posted On: 04/28/2020 5:37:02 PM
Post# of 36519
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Paul Jackson #15623
It’s not that AE37 doesn’t work on higher her2 expressing breast cancer patients, it’s that those control patients received Herceptin which is very effective. So DFS didn’t get the p value to show improvement. That was more of a trial design error much discussed in the past. Triple negative patients don’t benefit from Herceptin so we see a clearer comparison to access the vaccine.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)